Cardiovascular risk factors, smoking and kidney function

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 7, 1998, Pages 2-5

  Baggio, B ^a,b   Budakovic, A ^a   Gambaro, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Istituto di Medicina Interna di Padova   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CONFERENCE PAPER; KIDNEY FUNCTION; PRIORITY JOURNAL; SMOKING;

EID: 0031725716     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_7.2     Document Type: Conference Paper

References (48)

1. Lippman RH, Schattzke PD. Renal anatomy and nephropathology of aging. In: Zawad ETJ, Sica DA, eds. Geriatric Nephrology and Urology. PSG, Littleton, MA: 1985: 15-32
2. Mc Lachlan M. Anatomic structural functional relationships in the aging kidney. In: Nunez JFM, Cameron JS, eds. Renal Function and Disease in the Elderly. Butterworths, London: 1987; Vol. 31: 1153-1159
3. Wesson LG. Renal hemodynamics in physiological states. In: Wesson LG, ed. Physiology of the Human Kidney. Grune & Stratton, New York: 1969; 96 108
4. Rowe JW, Andres RA, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in man: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-163
5. Gambaro G, Valerio G. Baggio B et al. Renal functional reserve in the elderly. J Clin Exp Gerontol 1990; 12: 83 94
6. Lindeman RD, Tobin J, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984; 26: 861-868
7. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285
8. Feinfeld DA, Guzik H, Carvounis CP et al. Sequential changes in renal function tests in the old: results from the Bronx longitudinal aging study. J Am Geriatr Soc 1995; 43: 412-414
9. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997; 51: 1196-1204
10. Cokroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
11. Gambaro G, Budakovic A, Baggio B et al. Cigarette smoking is associated with altered hemodynamics. Proceedings of the XXXIII rd Congress EDTA-ERA, Amsterdam, The Netherlands, June 18-21, 1996; Nephrol Dial Transplant 1996; 11: A72
12. Gambaro G, Budakovic A, Baggio B et al. Cigarette smoking is associated with altered hemodynamics. Proceedings of the XXXIII rd Congress EDTA-ERA, Amsterdam, The Netherlands, June 18-21, 1996; Nephrol Dial Transplant 1996; 11: A72
13. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int 1997; 51: 1669-1677
14. The health consequenses of smoking: cardiovascular disease. US Department of Health and Human services, Office on Smoking and Health, Report of the Surgeon General. DHHS (PHS), Washigton DC: 1983; 84 50204
15. Franek E, Benk U, Reimbold F, Fliser D, Clorius J, Ritz E. Acute influence of smoking on renal function. Nephrol Dial Transplant 1996; 11: A65
16. Koch M, Thomas B, Tschopc W, Ritz E. Survival and predictors of death in dialysed diabetic patients. Diabetologia 1993; 36: 1113 1117
17. Biesenbach G, Gralingcr P, Zazgornik J. Influence of smoking on the survival rate of diabetic patients on hemodialysis. Diabetologia 1995; 38 [Suppl 1]: A209
18. Muhlauser I. Cgarette smoking and diabetes: an update Diabetic Med. 1994; 11: 336-341
19. Luke RG. Nephrosclerosis. In: Schrier RW, Gottschalk CW, eds. Diseases of the Kidney. 4th edn. Little Brown Co., Boston, MA: 1988: 1436
20. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking associated hemodynamic and metabolic events. New Engl J Med 1976; 295: 573-577
21. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet 1983; 1: 1248-125
22. 2 and prostacyclin metabolites in young men. Circulation 1991; 83: 1698 1704
23. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings. Am J Med 1993; 95: 71 77
24. Celermajer D, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation 1993; 88: 2149-2155
25. Kiowski W, Linder L, Stoschitzky K et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994; 90: 27 34
26. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43: 267 269
27. Kohan DE. Endothelin in the kidney: physiology and pathophysiology. Am J Kidney Dis 1993, 22: 493-510
28. King AJ, Brenner BM, Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 1989; 256: F1051-F1058
29. Lerman A, Hildebrand FL, Aarhus LL, Burnett J. Endothelin has biological actions at pathophysiological concentration. Circulation 1991; 83: 1808-1814
30. Black HR, Zeevi GR, Silten RM, Smith GJW. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron 1983; 34: 173 179
31. Oberai B, Adams CWM, High OB. Myocardial and renal arteriolar thickening in cigarette smoking. Atherosclerosis 1984; 52: 185-190
32. Brischetto CS, Connor WE, Connor SL, Matarazzo JD. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein. Am J Cardiol 1983; 52: 675-680
33. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med 1992; 43: 219 225
34. Schmidt A, Bunte A, Buddeeke E. Proliferation-dependent changes of proteoglycan metabolism in arterial smooth muscle cells. Biol Chem Hoppe-Seyler 1987; 368: 277 284
35. Camejo G, Acquatella H, Lalaguna F. The interaction of low density lipoproteins with arterial proteoglycan: an additional risk factor. Atherosclerosis 1980; 36: 55-65
36. Ziad A, Keane M, Keane WF. Pathogenesis of atherosclerosis. Semin Nephrol 1996; 16: 12-20
37. Hibert LM, Liu J. Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis 1990; 83: 47
38. Murata K, Horiuchi Y. Age-dependent distribution of acidic glycosaminoglycans in human kidney tissue. Nephron 1978; 20: 111-118
39. Cohen MP, Ku L. Age-related changes in sulfation of basement membrane glycosaminoglycans. Exp Gerontol 1983; 18: 447-450
40. Sudey I, Bakala H, Perichon M, Schacverbeke J. Age-related changes in the plasma membrane proteoglycans of rat kidney glomerular cells. Exp Gerontol 1991; 26: 573 587
41. Gambaro G, Brunello A, Vincenti M, Nassuato MA, Bertaglia G, Baggio B. Renal tubular function in the elderly. Contrib Nephrol 1993; 105: 81-84
42. Humphries DE, Lee SL, Fanburg BL, Silbert JE. Effects of hypoxia and hyperoxia on proteoglycan production by bovine pulmonary artery endothelial cells. J Cell Physiol 1986; 126: 249 253
43. Kashihara N, Watanabe Y, Makino H, Wallner EI, Kanwar Y. Selective decrease in de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 1992; 89: 6309-6313
44. Gambaro G, Baggio B. Role of glycosaminoglycans in diabetic nephropathy. Acta Diabetol 1992; 29: 149-155
45. Gambaro G, Baggio B. Glycosaminoglycans: a new paradigm in the prevention of proteinuria and progression? Nephrol Dial Transplant 1996; 11: 762 764
46. Ross R. The pathogenesis of atherosclerosis: perspective for the 1990s. Nature 1993; 362: 801-809
47. Diamond JR. Analogous pathobiologic mechanism in glomerulosclerosis and atherosclerosis. Kidney Int 1991; 39[Suppl 31]: S29-S34
48. Baylis C, Schmidt R. The aging glomerulus. Semin Nephrol 1996; 16: 265-276